Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-06-13 Purchase | 2022-06-17 4:14 pm | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO 10% Owner | 88,154 | $3.0912 | $272,506 | 1,741,894 (Indirect Direct) | View |
| 2021-11-17 Purchase | 2021-11-19 4:10 pm | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO | 400,000 | $0.985 | $394,000 | 16,531,891 (Indirect Direct) | View |
| 2021-08-18 Purchase | 2021-08-20 4:27 pm | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO | 480,000 | $1.2788 | $613,800 | 16,137,413 (Indirect Direct) | View |
| 2021-03-26 Purchase | 2021-03-30 4:52 pm | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO | 3,000,000 | $2.05 | $6,150,000 | 15,657,413 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-06-15 Option Award | 2021-06-16 4:01 pm | N/A 2031-04-27 | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO 10% Owner | 4,000,000 | $0 | 4,000,000 (Direct) | View |
| 2020-12-22 Gift | 2020-12-23 4:02 pm | N/A N/A | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO | 380,000 | $0 | 12,657,413 (Direct) | View |